Home539871 • BOM
add
Thyrocare Technologies Ltd
Previous close
₹783.90
Day range
₹771.80 - ₹784.05
Year range
₹555.85 - ₹1,053.05
Market cap
41.38B INR
Avg Volume
5.97K
P/E ratio
47.11
Dividend yield
2.31%
Primary exchange
NSE
Market news
FXStreet
50 minutes ago
Dow Jones Industrial Average middles on Thursday after mixed data and
earnings
1.76%
0.24%
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.66B | 23.14% |
Operating expense | 610.00M | 17.67% |
Net income | 191.10M | 24.50% |
Net profit margin | 11.52 | 1.14% |
Earnings per share | 3.56 | — |
EBITDA | 342.68M | 31.98% |
Effective tax rate | 32.13% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.38B | 38.47% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 4.89B | — |
Shares outstanding | 52.99M | — |
Price to book | 8.58 | — |
Return on assets | — | — |
Return on capital | 12.16% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 191.10M | 24.50% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,693
